Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines
about
An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 linkIRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latencyEpstein-Barr virus microRNAs are evolutionarily conserved and differentially expressedEpstein-Barr virus and host cell methylation: regulation of latency, replication and virus reactivationVirus-encoded homologs of cellular interleukin-10 and their control of host immune function.Characterization of murine cathepsin W and its role in cell-mediated cytotoxicity.Epstein-Barr virus latency switch in human B-cells: a physico-chemical model.Epstein-Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expressionMechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates.CTCF prevents the epigenetic drift of EBV latency promoter QpThe Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitiveEstablishment and characterization of a human Epstein-Barr virus-associated gastric carcinoma in SCID miceInterferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1Epstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2ADNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirusEBNA-1: a protein pivotal to latent infection by Epstein-Barr virus.Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors.Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency.EBV latency types adopt alternative chromatin conformations.Viral latency and its regulation: lessons from the gamma-herpesviruses.Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency.Epstein-Barr virus nuclear antigen 3A promotes cellular proliferation by repression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1.Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation.Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions.Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.Unexpected patterns of Epstein-Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA.Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.trans-Repression of protein expression dependent on the Epstein-Barr virus promoter Wp during latency.Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors.The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activityActivation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F.Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells.A simple reverse transcriptase PCR assay to distinguish EBNA1 gene transcripts associated with type I and II latency from those arising during induction of the viral lytic cycleThe Epstein-Barr virus EBNA-1 promoter Qp requires an initiator-like element.Interferon-independent and -induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt lymphoma.Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cellsImmunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection.Cell cycle association of the retinoblastoma protein Rb and the histone demethylase LSD1 with the Epstein-Barr virus latency promoter Cp.Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programsEBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance.
P2860
Q21131584-96ACED4E-4A1B-4008-B221-DF6DF0989AB5Q24315695-B0FDDB00-9F76-468F-BEE7-B189204ABEA9Q25257225-F7B03C5F-C12A-479C-AD8E-CA2DFA668F97Q26863256-931CD815-FB52-4C9F-914B-F096DCC42845Q30436621-CB096CF1-9D34-411A-80CA-D8F52ADA46B9Q33201672-FD70E3F0-8A4D-416A-B1D0-4405464211E9Q33296308-75BB2F97-C01F-4466-A0CA-2B2C4F9BB26EQ33641167-76EA87F2-C731-4525-8EDE-E8B382444965Q33653017-F64634B0-03CC-40E3-B107-20B589952CDBQ33668727-BE57058D-84BC-4934-9172-66695CB5CEA1Q33783746-3345ADB4-3D93-4AFD-8E15-C723E06F1C2FQ33784983-EF825812-3B0C-47CD-ADC1-CE2AB24068F9Q33792860-E39116BC-9579-47CE-97BF-A4D47F7D4328Q33794029-27896BB4-06AF-4D44-87C5-0176B744A3DCQ33853499-B90BF2D8-52CA-496F-BA9F-93C78E1A5AFBQ33860748-F3832606-772B-4C79-8D48-6320E8859073Q33866046-032F8EFD-F04A-4897-AE72-B2395C94A23DQ33957851-6D5317DA-8384-4DC0-9646-0B0F79083027Q33987454-920A8D58-1A76-43B7-AC76-9246602F4EDDQ34039189-08478D67-49A2-4D71-80F9-7CA7D451FB11Q34236524-C353A37A-35B8-4A1A-BDBC-054517C96C72Q34283174-16FA9A4A-25EE-4E4D-8A02-AEC626E7159EQ34485302-02A809C9-D3E5-42F4-930A-930B1583DEA6Q34576340-69A341D7-85A0-4117-A24C-229E16DB785DQ34658852-88347885-F7CF-4683-B2C1-0764BFAE4E53Q34703035-D65A0E16-4F85-4E8B-94DE-0DE37F33E693Q35122260-16FC6742-8729-40BC-BD93-E52F0963E4FBQ35363296-F053E4A0-19C1-4B6F-91C1-E9730443E3D5Q35414637-C4F6FFB3-6219-4937-BDA5-07A473CDA817Q35603820-FBD79BB9-8C1B-4266-BD8C-E7189CA7D5ABQ35859223-39B0C580-CFE4-44DC-98F8-9E4AAEA0E881Q35861192-0BD1EED5-B15C-4696-8EBC-3DC76B900A56Q35872919-FA3913AD-790E-4D3B-8BA4-1C6EA0978D01Q35874869-8DE23211-64E8-46E2-88AC-6532F4D9F8AFQ35892261-74BE0B2C-3645-4167-9607-C4B9367BC4DBQ36135900-5B9165A3-7AFB-47D1-8835-F2B83BC12B28Q36498133-DCB07438-5D17-4695-90A8-46D98096EC61Q36498238-DB1B5343-708E-48DB-9465-239B94A939BFQ36564877-F2F2D237-459C-4BD5-8970-0DB66E37A7B3Q37093792-2E4CA04E-1128-4C7A-AF12-AE94D2BE0A28
P2860
Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines
description
1995 nî lūn-bûn
@nan
1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Redefining the Epstein-Barr vi ...... I Burkitt lymphoma cell lines
@ast
Redefining the Epstein-Barr vi ...... I Burkitt lymphoma cell lines
@en
type
label
Redefining the Epstein-Barr vi ...... I Burkitt lymphoma cell lines
@ast
Redefining the Epstein-Barr vi ...... I Burkitt lymphoma cell lines
@en
prefLabel
Redefining the Epstein-Barr vi ...... I Burkitt lymphoma cell lines
@ast
Redefining the Epstein-Barr vi ...... I Burkitt lymphoma cell lines
@en
P2860
P356
P1476
Redefining the Epstein-Barr vi ...... I Burkitt lymphoma cell lines
@en
P2093
B C Schaefer
P2860
P304
10565-10569
P356
10.1073/PNAS.92.23.10565
P407
P577
1995-11-01T00:00:00Z